Insider · CIK 0001829958
Suresh K. Durgam
officer
Files at ITCI (Intra-Cellular Therapies, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Common Stock | -42,913 | $132.00 | $5.7M | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -53,967 | - | - | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -33,443 | - | - | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -18,714 | - | - | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -17,916 | - | - | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -13,133 | - | - | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -17,485 | - | - | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -24,621 | - | - | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | AGrant or award Performance Stock Unitsderivative | +13,134 | $0.00 | $0 | 13,134 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Performance Stock Unitsderivative | -13,134 | - | - | 0 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | AGrant or award Performance Stock Unitsderivative | +8,742 | $0.00 | $0 | 8,742 | Apr 2, 2025 |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | DDisposition to issuer Performance Stock Unitsderivative | -8,742 | - | - | 0 | Apr 2, 2025 |
| Mar 6, 2025 | ITCI Intra-Cellular Therapies, Inc. | MOption exercise Common Stock | +13,133 | - | - | 44,256 | Mar 10, 2025 |
| Mar 6, 2025 | ITCI Intra-Cellular Therapies, Inc. | FTax withholding Common Stock | -5,572 | $131.19 | $731k | 38,684 | Mar 10, 2025 |
| Mar 10, 2025 | ITCI Intra-Cellular Therapies, Inc. | MOption exercise Common Stock | +7,345 | - | - | 46,029 | Mar 10, 2025 |
| Mar 10, 2025 | ITCI Intra-Cellular Therapies, Inc. | FTax withholding Common Stock | -3,116 | $131.24 | $409k | 42,913 | Mar 10, 2025 |
| Mar 6, 2025 | ITCI Intra-Cellular Therapies, Inc. | MOption exercise Restricted Stock Unitsderivative | -13,133 | $0.00 | $0 | 13,133 | Mar 10, 2025 |
| Mar 10, 2025 | ITCI Intra-Cellular Therapies, Inc. | MOption exercise Restricted Stock Unitsderivative | -7,345 | $0.00 | $0 | 0 | Mar 10, 2025 |
| Mar 1, 2025 | ITCI Intra-Cellular Therapies, Inc. | MOption exercise Common Stock | +8,742 | - | - | 34,832 | Mar 4, 2025 |
| Mar 1, 2025 | ITCI Intra-Cellular Therapies, Inc. | FTax withholding Common Stock | -3,709 | $128.20 | $475k | 31,123 | Mar 4, 2025 |
| Mar 1, 2025 | ITCI Intra-Cellular Therapies, Inc. | MOption exercise Restricted Stock Unitsderivative | -8,742 | $0.00 | $0 | 17,485 | Mar 4, 2025 |
| Jan 31, 2025 | ITCI Intra-Cellular Therapies, Inc. | AGrant or award Common Stock | +11,017 | $0.00 | $0 | 30,820 | Feb 4, 2025 |
| Jan 31, 2025 | ITCI Intra-Cellular Therapies, Inc. | FTax withholding Common Stock | -4,730 | $127.00 | $601k | 26,090 | Feb 4, 2025 |
| Feb 3, 2025 | ITCI Intra-Cellular Therapies, Inc. | AGrant or award Restricted Stock Unitsderivative | +24,621 | $0.00 | $0 | 24,621 | Feb 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.